Company / Operating Cash Flow per Share
Sunshine Biopharma Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.85
FY2025
5-year range
-$626.26 / -$0.23
FY2021-FY2025
Trend
+99.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-626.26 in FY2024 to $-0.00 in FY2017.
Based on SEC 10-K filings.
-4.85 in FY2025.
Declined from $-0.23 to $-4.85 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 99.2% year-over-year.
- Peak operating cash flow per share was recorded in FY2017.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.85 | +99.2% |
| FY2024 | -$626.26 | -269401.6% |
| FY2023 | -$0.23 | +67.1% |
| FY2022 | -$0.71 | -86.0% |
| FY2021 | -$0.38 | -2603.4% |
| FY2020 | -$0.01 | +88.3% |
| FY2019 | -$0.12 | -912.0% |
| FY2018 | -$0.01 | -2797.5% |
| FY2017 | -$0.00 | +90.7% |
| FY2016 | -$0.00 | +40.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026